Skip to main content

and
  1. Article

    Open Access

    Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

    After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-yea...

    HP Knaebel, A Märten, J Schmidt, K Hoffmann, C Seiler, K Lindel in BMC Cancer (2005)